Assessing healthcare simulation facilitation using a competency-based tool derived from practice in low-resource settings.

Mossenson AI, Brown JA, Tuyishime E, Rubio Martinez R, Khalid K, Livingston P

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.

Chalmers JD, Burgel PR, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML, ASPEN Investigators

C2L3-Fusion: An Integrated 3D Object Detection Method for Autonomous Vehicles.

Ngo TB, Ngo L, Phi AV, Nguyen TTHT, Nguyen A, Brown J, Perera A

Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis.

Yilma D, Stepniewska K, Bousema T, Drakeley C, Eachempati P, Guerin PJ, Mårtensson A, Mwaiswelo R, Taylor WR, Barnes KI, WWARN Paediatric Primaquine for P falciparum Transmission Blocking Study Group

A mixed-mode LC-MS-based method for comprehensive analysis of NAD and related metabolites from biological sample matrices.

Nacham O, Brown JW, Maneshi MM, Kurschner V, Sheehan M, Sadowski R, Ling C, Talaty N, Johnson R, Swensen AM

The effect of 0.5 mL mepivacaine administered as an abaxial sesamoid nerve block on lameness of horses with digital pain did not differ significantly from that of 2.5 mL of mepivacaine.

Cole RC, DeGraves FJ, Brown J, Schumacher J

Comparison of methods for faecal hormone preservation and analysis in African savanna elephants under field conditions.

Chusyd DE, Chester E, Steiniche T, Dickinson S, Ortyl B, Paris S, Boisseau N, Wasserman M, Brown JL

Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study.

Brown JR, Li J, Eichhorst BF, Lamanna N, O'Brien SM, Tam CS, Qiu L, Huang R, Shi Y, Idoine A, Salmi T, Cohen AC, Shadman M

Hypoxia-Responsive Polymersomes for Stemness Reduction in Patient-Derived Solid Tumor Spheroids.

Edvall C, Kale N, Tani S, Ambhore S, Hossain R, Ozoude C, Van Horsen K, Mohammad J, Tuvin DM, Kalathingal S, Loganathan J, Choi Y, Sathish V, Brown J, Mallik S

Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Davids MS, Ryan CE, Lampson BL, Ren Y, Tyekucheva S, Fernandes SM, Crombie JL, Kim AI, Weinstock M, Montegaard J, Walker HA, Greenman C, Patterson V, Jacobson CA, LaCasce AS, Armand P, Fisher DC, Lo S, Olszewski AJ, Arnason JE, Ahn IE, Brown JR